As Shanghai Huihe Medical Technology Co., Ltd. and its sponsors Dongwu Securities Co., Ltd. and Cathay Pacific Haitong Securities Co., Ltd. withdrew their issuance and listing applications, the Shanghai Stock Exchange terminated the review of their initial public offering of shares and listing on the Science and Technology Innovation Board in accordance with the relevant provisions of Article 63 of the “Shanghai Stock Exchange Stock Issuance and Listing Review Rules”. On July 1, the China Securities Association announced the on-site inspection and spot check list for the fourth batch of startup companies in 2026. A total of 21 companies were selected, including Huihe Healthcare.
Zhitongcaijing · 3d ago
Share
Listen to the news
As Shanghai Huihe Medical Technology Co., Ltd. and its sponsors Dongwu Securities Co., Ltd. and Cathay Pacific Haitong Securities Co., Ltd. withdrew their issuance and listing applications, the Shanghai Stock Exchange terminated the review of their initial public offering of shares and listing on the Science and Technology Innovation Board in accordance with the relevant provisions of Article 63 of the “Shanghai Stock Exchange Stock Issuance and Listing Review Rules”. On July 1, the China Securities Association announced the on-site inspection and spot check list for the fourth batch of startup companies in 2026. A total of 21 companies were selected, including Huihe Healthcare.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending